SCLXW实时信号 | 通过Getagraph.com最大化利润

Live Chart Being Loaded With Signals

Commentary (29 Jun 2024 @ 04:00):
Our systems believe the stock currently is overvalued by -0.25% compare to its pairs and should correct downwards.

Scilex Holding Company, a biopharmaceutical company, focuses on developing and commercializing non-opioid therapies for patients with acute and chronic pain...

Stats
今日成交量	93 590
平均成交量	0
市值	320.69M
EPS	$-0.240 ( Q1 \| 2024-05-13 )
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	0 (Sector) 42.63 (Industry) 61.14
ATR14	$0.0210 (4.67%)

CRXT -31.16%

MIRA -2.00%

SCLX 7.82%

SCLXW 5.24%

Insider Trading

Date	Person	Action	Amount	type
2023-10-04	Ji Henry	Buy	200 000	Nonstatutory Stock Option (right to buy)
2023-10-04	Shah Jaisim	Buy	200 000	Nonstatutory Stock Option (right to buy)
2023-10-04	Wu Yue Alexander	Buy	250 000	Nonstatutory Stock Option (right to buy)
2023-10-04	Chun Jay	Buy	250 000	Nonstatutory Stock Option (right to buy)
2023-10-04	Ma Stephen Hoi	Buy	150 000	Nonstatutory Stock Option (right to buy)

INSIDER POWER
-88.45
Last 30 transactions
Buy: 13 352 730 \| Sell: 150 694 281

相关性 (AI algo v.1.1b): Overvalued: -0.25% $0.451 paired level. (算法实时跟踪最相关股票的变化并提供即时更新)

音量相关性

長: -0.19 (neutral)

短: -0.55 (weak negative)

Signal:(52.69) Neutral

Scilex Holding Company 相关性

10 最正相关

10 最负相关

你知道吗？

相关性是描述两个变量之间关系的统计指标。它的取值范围为-1到1，其中-1表示完全负相关（一个变量增加，另一个变量减少），1表示完全正相关（一个变量增加，另一个变量也增加），0表示没有相关性（变量之间没有关系）。

相关性可用于分析任何两个变量之间的关系，而不仅仅是股票。它通常用于金融、经济学、心理学等领域。

Scilex Holding Company 相关性 - 货币/商品

-0.24
( neutral )

-0.34
( neutral )

0.00
( neutral )

0.12
( neutral )

0.34
( neutral )

0.23
( neutral )

Scilex Holding Company 财务报表

Annual	2023
营收:	$46.74M
毛利润:	$26.92M (57.58 %)
EPS:	$-0.880

FY	2023
营收:	$46.74M
毛利润:	$26.92M (57.58 %)
EPS:	$-0.880

FY	2022
营收:	$38.03M
毛利润:	$27.24M (71.61 %)
EPS:	$-0.170

Financial Reports:

No articles found.

Scilex Holding Company Options Data

Calls

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Puts

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Scilex Holding Company

Scilex Holding Company, a biopharmaceutical company, focuses on developing and commercializing non-opioid therapies for patients with acute and chronic pain. The company\'s principal product includes ZTlido 1.8%, a prescription lidocaine topical product for the relief of neuropathic pain related with post-herpetic neuralgia, which is a form of post-shingles nerve pain. It also offers SP-102 or SEMDEXA, a viscous gel formulation of corticosteroid for epidural injections that is in a Phase 3 clinical trial to treat lumbosacral radicular pain; SP-103 for the treatment of low back pain, which is in Phase 2 clinical trails; and SP-104, a novel low-dose delayed-release naltrexone hydrochloride formulation for the treatment of fibromyalgia that is in Phase 1 clinical trials. The company is headquartered in Palo Alto, California. Scilex Holding Company is a subsidiary of Sorrento Therapeutics, Inc.